MEAGHAN CATON: Open Payments
NPI 1134660285 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,646 in 92 payments from 19 companies in 2025. Trend: 2023 $1,913 · 2024 $2,075 · 2025 $1,646
Food & beverage: $1,646
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $243 |
| Amgen Inc. | 9 | $158 |
| AstraZeneca Pharmaceuticals LP | 9 | $146 |
| PFIZER INC. | 8 | $142 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $135 |
| ABBVIE INC. | 6 | $115 |
| Abbott Laboratories | 6 | $104 |
| Sumitomo Pharma America, Inc. | 7 | $102 |
| GlaxoSmithKline, LLC. | 4 | $80 |
| INTUITIVE SURGICAL, INC. | 1 | $77 |
Products named: Kerendia, KRYSTEXXA, ELIQUIS, FREESTYLE LIBRE 3, GEMTESA, Ozempic, AIRSUPRA, Wegovy.
Industry payments across AL — which companies pay providers there.
